Oregon
Prescription drug spending and prescribing in Oregon, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $3.0B for prescriptions written in Oregon, the 30th most of 52 states and territories, and 4.7% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $3.0B
- Medicaid drugs, 2025: $1.0B
- Opioid share of claims: 4.7%
- Life-science raises, 2 years: $127M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Oregon | United States | Difference |
|---|---|---|---|
| Opioids | 4.7% | 3.5% | +33% |
| Antibiotics | 3.8% | 4.4% | -14% |
| Antipsychotics | 1.9% | 1.7% | +11% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Oregon's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Fluoride (Sodium) | 4.4× | 24,062 |
| Ciclesonide | 4.1× | 10,095 |
| Beclomethasone Dipropionate | 3.1× | 8,120 |
| Buprenorphine Hcl | 3.0× | 19,862 |
| Dabigatran Etexilate Mesylate | 2.8× | 25,052 |
| Insulin Glargine-Yfgn | 2.8× | 18,650 |
| Progesterone, Micronized | 2.6× | 19,262 |
| Insulin Nph Human Isophane | 2.5× | 17,360 |
| Oxycodone Hcl | 2.5× | 269,284 |
| Methadone Hcl | 2.2× | 14,046 |
Biggest Medicaid Drugs
What Oregon's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
27 Form D raises by companies based in Oregon in the last two years; the 10 largest. See all raises- Sparrow Pharmaceuticals, Inc.$62M · Pharma · Jul 1, 2025
- Ceek Women's Health, Inc.$20M · Other health care · Feb 21, 2025
- Trace Biosciences Inc.$8M · Biotech · Aug 12, 2026
- Functional Brands Inc.$8M · Other health care · Nov 10, 2025
- Ceek Women's Health, Inc.$7M · Other health care · Jun 18, 2026
- Rare Air Health, Inc.$5M · Other health care · Jan 2, 2026
- Pacific Diabetes Technologies, Inc.$3M · Biotech · Oct 20, 2025
- Remedtx, Inc.$3M · Other health care · Apr 7, 2026
- Pacific Diabetes Technologies, Inc.$2M · Biotech · Mar 14, 2025
- Siloam Vision, Inc.$1M · Other health care · Jan 28, 2026
State Attorney General Health-Care Cases
Antitrust cases Oregon joined, newest first; see every case- Plaintiff States and FTC v. CVET TOPCO, L.P. et al.2026 · Pending
- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Florida et al. v. Abbott Laboratories et al., No. 1:08-cv-00155-SLR (D.Del. 2007)2007 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)2005 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG